| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiomyopathy, Hypertrophic | 34 | 2011 | 116 | 4.220 |
Why?
|
| Heart Septum | 27 | 2011 | 84 | 2.800 |
Why?
|
| Ethanol | 26 | 2011 | 893 | 2.010 |
Why?
|
| Catheter Ablation | 12 | 2008 | 229 | 1.030 |
Why?
|
| Ventricular Outflow Obstruction | 8 | 2011 | 36 | 0.850 |
Why?
|
| Clinical Deterioration | 1 | 2019 | 4 | 0.680 |
Why?
|
| Cardiac Pacing, Artificial | 10 | 2008 | 174 | 0.640 |
Why?
|
| Critical Illness | 1 | 2019 | 191 | 0.600 |
Why?
|
| Hospital Mortality | 1 | 2019 | 384 | 0.590 |
Why?
|
| Ventricular Function, Left | 8 | 2008 | 481 | 0.570 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 711 | 0.440 |
Why?
|
| Cardiac Catheterization | 8 | 2008 | 419 | 0.440 |
Why?
|
| Ablation Techniques | 1 | 2011 | 33 | 0.390 |
Why?
|
| Echocardiography, Doppler | 9 | 2008 | 87 | 0.360 |
Why?
|
| Echocardiography | 12 | 2003 | 515 | 0.350 |
Why?
|
| Middle Aged | 36 | 2019 | 21147 | 0.340 |
Why?
|
| Angioplasty, Balloon, Coronary | 5 | 2005 | 178 | 0.330 |
Why?
|
| Aged | 28 | 2019 | 14862 | 0.320 |
Why?
|
| Follow-Up Studies | 13 | 2008 | 3259 | 0.310 |
Why?
|
| Arrhythmias, Cardiac | 4 | 2003 | 239 | 0.310 |
Why?
|
| Catheterization | 1 | 2008 | 209 | 0.300 |
Why?
|
| Defibrillators, Implantable | 4 | 2010 | 329 | 0.300 |
Why?
|
| Myocardial Infarction | 8 | 2005 | 807 | 0.290 |
Why?
|
| Male | 39 | 2019 | 37321 | 0.260 |
Why?
|
| Hemodynamics | 6 | 2003 | 705 | 0.260 |
Why?
|
| Female | 38 | 2019 | 38074 | 0.260 |
Why?
|
| Humans | 52 | 2019 | 68618 | 0.250 |
Why?
|
| Tachycardia, Ventricular | 2 | 2005 | 153 | 0.250 |
Why?
|
| Heart Block | 5 | 2008 | 49 | 0.250 |
Why?
|
| Prospective Studies | 9 | 2019 | 3705 | 0.240 |
Why?
|
| Papillary Muscles | 1 | 2004 | 30 | 0.230 |
Why?
|
| Pacemaker, Artificial | 6 | 2007 | 157 | 0.230 |
Why?
|
| Long QT Syndrome | 1 | 2003 | 14 | 0.220 |
Why?
|
| Adult | 20 | 2019 | 21403 | 0.210 |
Why?
|
| Injections | 4 | 2004 | 119 | 0.200 |
Why?
|
| Dyspnea | 3 | 2011 | 87 | 0.180 |
Why?
|
| Electrocardiography | 8 | 2005 | 601 | 0.180 |
Why?
|
| Aged, 80 and over | 9 | 2005 | 4848 | 0.180 |
Why?
|
| Complementary Therapies | 1 | 2000 | 43 | 0.180 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2001 | 140 | 0.180 |
Why?
|
| Ventricular Dysfunction, Left | 4 | 2010 | 277 | 0.180 |
Why?
|
| Treatment Outcome | 12 | 2010 | 7029 | 0.170 |
Why?
|
| Atrial Function, Left | 1 | 1999 | 10 | 0.170 |
Why?
|
| Exercise Test | 6 | 2003 | 242 | 0.170 |
Why?
|
| Ventricular Remodeling | 2 | 2005 | 318 | 0.170 |
Why?
|
| Cardiomyopathy, Restrictive | 1 | 1998 | 6 | 0.160 |
Why?
|
| Australia | 1 | 2019 | 235 | 0.160 |
Why?
|
| Heart Atria | 3 | 1999 | 206 | 0.160 |
Why?
|
| ROC Curve | 1 | 2019 | 392 | 0.160 |
Why?
|
| Albumins | 1 | 1998 | 72 | 0.160 |
Why?
|
| Subclavian Vein | 1 | 1998 | 17 | 0.150 |
Why?
|
| Phlebography | 1 | 1998 | 31 | 0.150 |
Why?
|
| Registries | 3 | 2011 | 733 | 0.150 |
Why?
|
| Stroke Volume | 4 | 2011 | 586 | 0.150 |
Why?
|
| Contrast Media | 2 | 1998 | 595 | 0.150 |
Why?
|
| Exercise Tolerance | 3 | 2008 | 75 | 0.150 |
Why?
|
| Risk Assessment | 6 | 2019 | 2007 | 0.150 |
Why?
|
| Prosthesis Implantation | 1 | 1998 | 83 | 0.140 |
Why?
|
| Intensive Care Units | 1 | 2019 | 344 | 0.140 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 1465 | 0.140 |
Why?
|
| Tachycardia | 1 | 1996 | 53 | 0.140 |
Why?
|
| Creatine Kinase | 3 | 2003 | 46 | 0.140 |
Why?
|
| Injections, Intra-Arterial | 2 | 2008 | 30 | 0.140 |
Why?
|
| Death, Sudden, Cardiac | 3 | 2008 | 141 | 0.130 |
Why?
|
| Embolization, Therapeutic | 1 | 1998 | 150 | 0.130 |
Why?
|
| Foreign-Body Migration | 1 | 1996 | 38 | 0.130 |
Why?
|
| Postoperative Complications | 5 | 2005 | 1615 | 0.120 |
Why?
|
| Ischemic Attack, Transient | 1 | 1996 | 167 | 0.120 |
Why?
|
| Heart Conduction System | 3 | 2000 | 119 | 0.120 |
Why?
|
| Prognosis | 1 | 2019 | 2093 | 0.120 |
Why?
|
| Mitral Valve Insufficiency | 3 | 2008 | 99 | 0.120 |
Why?
|
| Physical Exertion | 1 | 1994 | 75 | 0.110 |
Why?
|
| Coronary Angiography | 4 | 2011 | 866 | 0.110 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 2 | 2005 | 85 | 0.110 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2011 | 189 | 0.110 |
Why?
|
| Diastole | 3 | 2003 | 161 | 0.100 |
Why?
|
| Analysis of Variance | 4 | 2003 | 1040 | 0.100 |
Why?
|
| Angina, Unstable | 1 | 2011 | 50 | 0.100 |
Why?
|
| North America | 1 | 2011 | 112 | 0.100 |
Why?
|
| Ultrasonography | 2 | 2004 | 453 | 0.100 |
Why?
|
| Ultrasonography, Interventional | 1 | 2011 | 119 | 0.090 |
Why?
|
| Angina Pectoris | 2 | 2008 | 61 | 0.090 |
Why?
|
| Differential Threshold | 1 | 2010 | 27 | 0.090 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 3 | 2005 | 137 | 0.090 |
Why?
|
| Texas | 3 | 2008 | 92 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2008 | 536 | 0.090 |
Why?
|
| Electric Countershock | 1 | 2010 | 130 | 0.090 |
Why?
|
| Activities of Daily Living | 1 | 1990 | 319 | 0.080 |
Why?
|
| Coronary Aneurysm | 1 | 2008 | 19 | 0.080 |
Why?
|
| Solvents | 2 | 2007 | 109 | 0.080 |
Why?
|
| Time Factors | 3 | 2008 | 4655 | 0.080 |
Why?
|
| Heart Rate | 1 | 1990 | 568 | 0.080 |
Why?
|
| Young Adult | 1 | 2019 | 5717 | 0.080 |
Why?
|
| Magnetics | 1 | 2007 | 52 | 0.070 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2007 | 52 | 0.070 |
Why?
|
| Cardiac Volume | 2 | 1999 | 21 | 0.070 |
Why?
|
| Coronary Disease | 3 | 2005 | 358 | 0.070 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2008 | 164 | 0.070 |
Why?
|
| Reproducibility of Results | 3 | 2002 | 2077 | 0.070 |
Why?
|
| Surgical Procedures, Operative | 2 | 1997 | 124 | 0.060 |
Why?
|
| Mitral Valve | 2 | 1999 | 166 | 0.060 |
Why?
|
| Anxiety | 1 | 2007 | 422 | 0.060 |
Why?
|
| Sclerosing Solutions | 1 | 2004 | 6 | 0.060 |
Why?
|
| Sclerotherapy | 1 | 2004 | 10 | 0.060 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2007 | 450 | 0.050 |
Why?
|
| Gated Blood-Pool Imaging | 1 | 2002 | 2 | 0.050 |
Why?
|
| Alcohols | 1 | 2002 | 13 | 0.050 |
Why?
|
| Developed Countries | 1 | 2002 | 8 | 0.050 |
Why?
|
| Sick Sinus Syndrome | 2 | 1994 | 18 | 0.050 |
Why?
|
| Angioplasty, Balloon | 1 | 2003 | 110 | 0.050 |
Why?
|
| Atrioventricular Node | 2 | 1994 | 39 | 0.050 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2003 | 98 | 0.050 |
Why?
|
| South Carolina | 1 | 2008 | 2752 | 0.050 |
Why?
|
| Matrix Metalloproteinases | 1 | 2002 | 223 | 0.050 |
Why?
|
| Atrial Function | 1 | 2000 | 8 | 0.050 |
Why?
|
| Cardiovascular Diseases | 3 | 1997 | 940 | 0.050 |
Why?
|
| Depression | 1 | 2007 | 943 | 0.050 |
Why?
|
| Chi-Square Distribution | 1 | 2001 | 546 | 0.040 |
Why?
|
| Aircraft | 2 | 1991 | 30 | 0.040 |
Why?
|
| Echocardiography, Transesophageal | 2 | 1997 | 100 | 0.040 |
Why?
|
| Transportation of Patients | 2 | 1991 | 46 | 0.040 |
Why?
|
| Atrial Fibrillation | 2 | 2003 | 249 | 0.040 |
Why?
|
| Internet | 1 | 2002 | 390 | 0.040 |
Why?
|
| Quality of Life | 1 | 2007 | 1515 | 0.040 |
Why?
|
| Electrocardiography, Ambulatory | 3 | 1997 | 34 | 0.040 |
Why?
|
| Heart | 3 | 2001 | 850 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2001 | 626 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2002 | 1342 | 0.040 |
Why?
|
| Necrosis | 1 | 1998 | 239 | 0.040 |
Why?
|
| Bradycardia | 1 | 1997 | 45 | 0.040 |
Why?
|
| Isoenzymes | 1 | 1998 | 308 | 0.040 |
Why?
|
| Retrospective Studies | 4 | 2007 | 7277 | 0.040 |
Why?
|
| Atrial Flutter | 1 | 1996 | 16 | 0.030 |
Why?
|
| Risk Factors | 2 | 2003 | 5731 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 1996 | 91 | 0.030 |
Why?
|
| Postoperative Care | 1 | 1996 | 163 | 0.030 |
Why?
|
| Adolescent | 3 | 2003 | 8912 | 0.030 |
Why?
|
| Dexamethasone | 1 | 1995 | 150 | 0.030 |
Why?
|
| Cardiac Output | 2 | 1994 | 133 | 0.030 |
Why?
|
| Probability | 2 | 2008 | 245 | 0.030 |
Why?
|
| Radiography | 1 | 1996 | 572 | 0.030 |
Why?
|
| Ventriculography, First-Pass | 1 | 1994 | 3 | 0.030 |
Why?
|
| Preoperative Care | 1 | 1996 | 275 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1997 | 689 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 1995 | 222 | 0.030 |
Why?
|
| Disease Progression | 1 | 1997 | 1038 | 0.030 |
Why?
|
| Patient Selection | 1 | 1996 | 592 | 0.030 |
Why?
|
| Coronary Artery Bypass | 3 | 1996 | 218 | 0.020 |
Why?
|
| United States | 1 | 2003 | 7367 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 1990 | 249 | 0.020 |
Why?
|
| Sex Factors | 2 | 2004 | 1266 | 0.020 |
Why?
|
| Thrombolytic Therapy | 1 | 1991 | 233 | 0.020 |
Why?
|
| Hemorrhage | 1 | 1991 | 328 | 0.020 |
Why?
|
| Dogs | 2 | 2000 | 490 | 0.020 |
Why?
|
| Injections, Intralesional | 1 | 2008 | 25 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2005 | 1851 | 0.020 |
Why?
|
| Tissue Plasminogen Activator | 1 | 1991 | 296 | 0.020 |
Why?
|
| Primary Prevention | 1 | 2008 | 115 | 0.020 |
Why?
|
| Myocardium | 2 | 2005 | 1204 | 0.020 |
Why?
|
| Salvage Therapy | 1 | 2007 | 82 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2007 | 216 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2008 | 951 | 0.020 |
Why?
|
| Survival Rate | 1 | 2008 | 1056 | 0.020 |
Why?
|
| Echocardiography, Stress | 1 | 2005 | 8 | 0.020 |
Why?
|
| Mental Health | 1 | 2007 | 278 | 0.020 |
Why?
|
| Metalloendopeptidases | 1 | 2005 | 67 | 0.020 |
Why?
|
| Exercise | 1 | 1990 | 658 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2005 | 254 | 0.020 |
Why?
|
| Cardiomyopathy, Hypertrophic, Familial | 1 | 2004 | 8 | 0.010 |
Why?
|
| Verapamil | 1 | 2003 | 30 | 0.010 |
Why?
|
| Recurrence | 1 | 2005 | 948 | 0.010 |
Why?
|
| Area Under Curve | 1 | 2002 | 238 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2002 | 2358 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2003 | 649 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2005 | 659 | 0.010 |
Why?
|
| Genetic Therapy | 1 | 2003 | 291 | 0.010 |
Why?
|
| Stress, Psychological | 1 | 2007 | 824 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2005 | 1553 | 0.010 |
Why?
|
| Body Surface Potential Mapping | 1 | 2000 | 10 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 2002 | 236 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2003 | 1046 | 0.010 |
Why?
|
| Models, Animal | 1 | 2000 | 252 | 0.010 |
Why?
|
| Logistic Models | 1 | 2003 | 1420 | 0.010 |
Why?
|
| Reference Values | 1 | 2000 | 579 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2007 | 2800 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1999 | 160 | 0.010 |
Why?
|
| Echocardiography, Doppler, Pulsed | 1 | 1999 | 3 | 0.010 |
Why?
|
| Incidence | 1 | 2003 | 1603 | 0.010 |
Why?
|
| Electrodes | 1 | 1999 | 147 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 1753 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2001 | 1174 | 0.010 |
Why?
|
| Fluoroscopy | 1 | 1999 | 152 | 0.010 |
Why?
|
| Biomarkers | 1 | 2003 | 1593 | 0.010 |
Why?
|
| Collagen | 1 | 2001 | 636 | 0.010 |
Why?
|
| Nitroglycerin | 1 | 1996 | 20 | 0.010 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 1996 | 20 | 0.010 |
Why?
|
| Electrodes, Implanted | 1 | 1995 | 98 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 1996 | 129 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 1996 | 138 | 0.010 |
Why?
|
| Heart Failure | 1 | 2004 | 1180 | 0.010 |
Why?
|
| Heart Diseases | 1 | 1997 | 276 | 0.010 |
Why?
|
| Cardiology | 1 | 1996 | 140 | 0.010 |
Why?
|
| Anesthesia | 1 | 1996 | 120 | 0.010 |
Why?
|
| Equipment Design | 1 | 1995 | 500 | 0.010 |
Why?
|
| Amyl Nitrite | 1 | 1973 | 1 | 0.010 |
Why?
|
| Kinetocardiography | 1 | 1973 | 1 | 0.010 |
Why?
|
| Cineangiography | 1 | 1973 | 15 | 0.010 |
Why?
|
| Heart Auscultation | 1 | 1973 | 5 | 0.010 |
Why?
|
| Societies, Medical | 1 | 1996 | 403 | 0.010 |
Why?
|
| Animals | 2 | 2000 | 20881 | 0.010 |
Why?
|
| Algorithms | 1 | 1997 | 1196 | 0.010 |
Why?
|
| Risk | 1 | 1991 | 563 | 0.010 |
Why?
|
| Work Capacity Evaluation | 1 | 1977 | 8 | 0.000 |
Why?
|
| Pulse | 1 | 1977 | 23 | 0.000 |
Why?
|